1. Achieving the Lowest Effective Antipsychotic Dose for Patients with Remitted Psychosis: A Proposed Guided Dose-Reduction Algorithm

   • Chen-Chung Liu
   • Hiroyoshi Takeuchi

   Current Opinion 18 November 2019 Pages: 117 - 126

   

2. Potential of Glioblastoma-Targeted Chimeric Antigen Receptor (CAR) T-Cell Therapy

   • Ryan D. Salinas
   • Joseph S. Durgin
   • Donald M. O’Rourke

   Leading Article 08 January 2020 Pages: 127 - 145

   

3. Pharmacological Management of the Genetic Generalised Epilepsies in Adolescents and Adults

   • Linda J. Stephen
   • Martin J. Brodie

   Review Article 25 January 2020 Pages: 147 - 161

   

4. Prescription of Valproate-Containing Medicines in Women of Childbearing Potential who have Psychiatric Disorders: Is It Worth the Risk?

   • David S. Baldwin
   • Hugo J. F. Amaro

   Review Article 16 December 2019 Pages: 163 - 169

5. Pharmacotherapy for Cluster Headache

   • Roemer B. Brandt
   • Patty G. G. Doesborg
   • Rolf Fronczek

   Review Article Open access 29 January 2020 Pages: 171 - 184

6. Diroximel Fumarate Demonstrates an Improved Gastrointestinal Tolerability Profile Compared with Dimethyl Fumarate in Patients with Relapsing–Remitting Multiple Sclerosis: Results from the Randomized, Double-Blind, Phase III EVOLVE-MS-2 Study

   • Robert T. Naismith
   • Annette Wundes
   • The EVOLVE-MS-2 Study Group

   Original Research Article Open access 17 January 2020 Pages: 185 - 196

   

7. Mortality Risk Associated with Haloperidol Use Compared with Other Antipsychotics: An 11-Year Population-Based Propensity-Score-Matched Cohort Study

   • Kim S. J. Lao
   • Angel Y. S. Wong
   • Esther W. Chan

   Original Research Article 08 January 2020 Pages: 197 - 206

   

8. Pitolisant: A Review in Narcolepsy with or without Cataplexy

   • Yvette N. Lamb

   Adis Drug Evaluation 29 January 2020 Pages: 207 - 218